The generic version of Dolutegravir, the most advanced drug against the AIDS virus, was introduced in Kenya. It is cheaper and will be introduced later in other regions.
The generic version of Dolutegravir has two advantages, according to an official of the organization Unitaid which aims to reduce the costs of drugs treating diseases such as AIDS or tuberculosis.
On one hand, it is very good on a purely pharmaceutical level, on the other hand, its price is much more advantageous.
For example, a box of 30 pills, equivalent to one month of treatment, costs between 14,500 and 29,000 CFA francs, where the generic version is sold at 2,300 CFA francs.
The distribution of the drug has started in Kenya for a few days, for 27,000 patients at first.
It will then be extended to the largest number. Similar programs will be launched by the end of the year in Nigeria and Uganda.
Around 37 million people are living with AIDS worldwide, including 25 million in Africa, according to figures published by the World Health Organization in 2015.